Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Chinot

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Oncogene|May 23, 2006
Identification of secondary structure in the 5'-untranslated region of the human adrenomedullin mRNA with implications for the regulation of mRNA translationF Brenet, N Dussault, C Delfino, et al.
Journal of Neuro-Oncology|November 27, 2015
Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcomeE Tabouret, C Boucard, R Devillier, et al.
Neuro-Chirurgie|November 18, 2004
[Hydroxyurea treatment for unresectable meningioma]S Fuentes, O Chinot, H Dufour, et al.
Journal of Neuro-Oncology|June 13, 2013
Limited impact of prognostic factors in patients with recurrent glioblastoma multiforme treated with a bevacizumab-based regimenE Tabouret, M Barrie, A Thiebaut, et al.
Revue Neurologique|August 6, 2008
[Neuropathology of lymphoma]D Uzenot, M Barrié-Attarian, S Attarian, et al.
Bulletin Du Cancer|May 27, 2009
[Prescription guidebook for temozolomide usage in brain tumors]P Tilleul, M Brignone, Y Hassani, et al.
International Journal of Cancer|March 29, 1995
Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancerS Romain, I J Christensen, O Chinot, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 16, 2017
IDH mutation is paradoxically associated with higher <sup>18</sup>F-FDOPA PET uptake in diffuse grade II and grade III gliomasA Verger, Ph Metellus, Q Sala, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 12, 2015
BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytomaE Tabouret, C Bequet, E Denicolaï, et al.
Journal of Neuro-Oncology|June 15, 2016
Coping with a newly diagnosed high-grade glioma: patient-caregiver dyad effects on quality of lifeK Baumstarck, T Leroy, Z Hamidou, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Oncogene|May 23, 2006
Identification of secondary structure in the 5'-untranslated region of the human adrenomedullin mRNA with implications for the regulation of mRNA translationF Brenet, N Dussault, C Delfino, et al.
Journal of Neuro-Oncology|November 27, 2015
Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcomeE Tabouret, C Boucard, R Devillier, et al.
Neuro-Chirurgie|November 18, 2004
[Hydroxyurea treatment for unresectable meningioma]S Fuentes, O Chinot, H Dufour, et al.
Journal of Neuro-Oncology|June 13, 2013
Limited impact of prognostic factors in patients with recurrent glioblastoma multiforme treated with a bevacizumab-based regimenE Tabouret, M Barrie, A Thiebaut, et al.
Revue Neurologique|August 6, 2008
[Neuropathology of lymphoma]D Uzenot, M Barrié-Attarian, S Attarian, et al.
Bulletin Du Cancer|May 27, 2009
[Prescription guidebook for temozolomide usage in brain tumors]P Tilleul, M Brignone, Y Hassani, et al.
International Journal of Cancer|March 29, 1995
Prognostic value of cytosolic thymidine kinase activity as a marker of proliferation in breast cancerS Romain, I J Christensen, O Chinot, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 16, 2017
IDH mutation is paradoxically associated with higher <sup>18</sup>F-FDOPA PET uptake in diffuse grade II and grade III gliomasA Verger, Ph Metellus, Q Sala, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 12, 2015
BRAF mutation and anaplasia may be predictive factors of progression-free survival in adult pleomorphic xanthoastrocytomaE Tabouret, C Bequet, E Denicolaï, et al.
Journal of Neuro-Oncology|June 15, 2016
Coping with a newly diagnosed high-grade glioma: patient-caregiver dyad effects on quality of lifeK Baumstarck, T Leroy, Z Hamidou, et al.
Pageof 6